Pain News and Research

Latest Pain News and Research

Henry Ford physicians use AngioVac device to remove tumor in kidney cancer patient

Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal.

13 Feb 2015

Tips to help manage migraine in children

Although we may think of migraine as a disease of adults, it can also affect children of all ages. Some studies show migraine affects 6% of children and up to 28% of adolescents ages 15-17. To assist parents whose children suffer from migraine, and to help the children themselves, the American Migraine Foundation and its Chair, David W. Dodick, MD, FRCP (C) are offering a number of tips to help manage childhood migraine and minimize its impact.

12 Feb 2015

Peanut-shaped exercise ball promotes positive labor outcomes, reduces duration of delivery process

According to a new study by nurse researchers at Banner Good Samaritan Medical Center, a Phoenix hospital part of Banner Health, a peanut-shaped exercise ball can be a highly effective tool to accelerate the labor process for women with an epidural. The research shows women utilizing the peanut ball were half as likely to undergo a cesarean surgery and delivered babies faster than those who did not use the ball.

12 Feb 2015

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015.

12 Feb 2015

TINA.org objects to proposed class-action settlement regarding Wellesse glucosamine supplement

Continuing its efforts to fight for settlements that are fair to consumers and mandate real changes in deceptive marketing, advocacy group truthinadvertising.org (TINA.org) has filed an objection in a proposed class-action settlement involving the brand-name glucosamine supplement, Wellesse®. Sold at retailers nationwide, the supplement is advertised as a joint pain remedy to ease pain and even rebuild cartilage.

12 Feb 2015

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).

11 Feb 2015

Diamond Headache Clinic's Alexander Feoktistov named recipient of 2015 NHF Lectureship

The National Headache Foundation is pleased to announce that Alexander Feoktistov, M.D., Ph.D., Director of Research at Diamond Headache Clinic, Chicago, Illinois, has been named the recipient of the 2015 NHF Lectureship. As the premier educational and informational resource for those living with headache disorders, their family members, physicians, allied health professionals, and health policy decision makers, the NHF created this award to preserve the highest level of neurobiological research and advancement in medicine today.

11 Feb 2015

Carma Laboratories' NEW Carmex Cold Sore Treatment named 2015 'Product of the Year' winner

Carma Laboratories, Inc., the manufacturer of Carmex lip balm products, is pleased to announce that its NEW Carmex Cold Sore Treatment has been named the 2015 "Product of the Year" winner in the Specialty Skin Treatment category by Product of the Year USA – the nation's largest consumer survey on product innovation.

11 Feb 2015

IOM committee identifies five main symptoms to diagnose ME/CFS

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome -- commonly referred to as ME/CFS -- is a legitimate, serious, and complex systemic disease that frequently and dramatically limits the activities of affected individuals, says a new report from the Institute of Medicine.

11 Feb 2015

DePuy Synthes announces acquisition of Olive Medical

Today DePuy Synthes Companies announced that it has acquired Olive Medical Corporation, a Utah-based privately held provider of high definition (HD) visualization systems for minimally invasive surgery (MIS). Financial terms of the transaction were not disclosed.

10 Feb 2015

St. John Hospital first in Michigan to offer new alternative treatment for acid reflux disease

St. John Hospital is among the first in the state and the only site in southeast Michigan to offer a new alternative treatment for patients with acid reflux disease.

10 Feb 2015

USA Vein Clinics to open new center in Marietta, GA

USA Vein Clinics, the nation's only coast-to-coast network of physicians devoted to treating venous insufficiency, will open a new center in Marietta, GA on Feb. 24 at 1050 E. Piedmont Road, north of Roswell Road.

10 Feb 2015

Synthetic Biologics reports positive results from SYN-004 Phase 1b trial to prevent C. difficile infection

Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.

10 Feb 2015

Chiasma announces publication of octreotide capsules Phase III study results in JCEM

Chiasma Inc., a U.S. privately-held biopharma company, announced today that results from a multicenter Phase III study of the investigational new drug, octreotide capsules, were published online for early release on Feb. 9, ahead of print, by the Journal of Clinical Endocrinology & Metabolism.

10 Feb 2015

Velano Vascular announces FDA approval of new blood-draw technology

Velano Vascular today announced that the U.S. Food and Drug Administration has granted marketing clearance for a new technology that provides an innovative approach to one of the most common procedures in medicine – the in-hospital blood draw.

10 Feb 2015

New study shows that chronic narcotic use more prevalent in children with IBD

Chronic narcotic use is more than twice as prevalent in children with inflammatory bowel disease (IBD), compared with children without this disease, according to a new study1 published in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association.

10 Feb 2015

Five researchers selected to receive 2015 Avant-Garde Award for HIV/AIDS Research

With proposals ranging from innovative therapies to the development of unique organoid models of the brain, five scientists have been selected to receive the 2015 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse, part of the National Institutes of Health. The five scientists will each receive $500,000 per year for five years to support their research.

10 Feb 2015

FDA accepts NDA filing for Inspirion Delivery Technologies' investigational drug, MorphaBond ER

Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.

10 Feb 2015

Physical, psychosocial factors can significantly increase risk of low back pain

New research reveals the physical and psychosocial factors that significantly increase the risk of low back pain onset. In fact results published in Arthritis Care & Research, a journal of the American College of Rheumatology, show that being engaged in manual tasks involving awkward positions will increase the risk of low back pain by eight times. Those who are distracted during activities or fatigued also significantly increase their risk of acute low back pain.

9 Feb 2015

Readmissions after surgery associated with new postdischarge complications, shows study

In a study that included readmission information from nearly 350 hospitals, readmissions the first 30 days after surgery were associated with new postdischarge complications related to the surgical procedure and not a worsening of any medical conditions the patient already had while hospitalized for surgery, according to a study in the February 3 issue of JAMA.

9 Feb 2015

Pain News and Research

Latest Pain News and Research

Henry Ford physicians use AngioVac device to remove tumor in kidney cancer patient

Tips to help manage migraine in children

Peanut-shaped exercise ball promotes positive labor outcomes, reduces duration of delivery process

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

TINA.org objects to proposed class-action settlement regarding Wellesse glucosamine supplement

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Diamond Headache Clinic's Alexander Feoktistov named recipient of 2015 NHF Lectureship

Carma Laboratories' NEW Carmex Cold Sore Treatment named 2015 'Product of the Year' winner

IOM committee identifies five main symptoms to diagnose ME/CFS

DePuy Synthes announces acquisition of Olive Medical

St. John Hospital first in Michigan to offer new alternative treatment for acid reflux disease

USA Vein Clinics to open new center in Marietta, GA

Synthetic Biologics reports positive results from SYN-004 Phase 1b trial to prevent C. difficile infection

Chiasma announces publication of octreotide capsules Phase III study results in JCEM

Velano Vascular announces FDA approval of new blood-draw technology

New study shows that chronic narcotic use more prevalent in children with IBD

Five researchers selected to receive 2015 Avant-Garde Award for HIV/AIDS Research

FDA accepts NDA filing for Inspirion Delivery Technologies' investigational drug, MorphaBond ER

Physical, psychosocial factors can significantly increase risk of low back pain

Readmissions after surgery associated with new postdischarge complications, shows study

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in